Jump to:

EKF Diagnostics Holdings Fundamentals

Company Name EKF Diagnostics Last Updated 16 Jul 2019
Industry Health Care Sector Medical Equipment
Shares in Issue (m) 455.16 Market Cap (£m) 163.86
PE Ratio 16.29 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS 2.21 EPS Growth (%) 274.58
PEG 0.06 DPS Growth (%) n/a
Debt Ratio 5.72 Debt Equity Ratio 0.22
Net Gearing 8.84 Gross Gearing 21.48
Asset Equity Ratio 1.27 Cash Equity Ratio 16.09
Quick Ratio 1.30 Current Ratio 1.75
Price To Book Value 2.56 ROCE 17.96

EKF Diagnostics Holdings Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

EKF Diagnostics Holdings Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 12 12 12
Intangible Assets 42 44 47
Investments 3 0 1
Total Fixed Assets 58 56 59
Stocks 6 6 6
Debtors 7 7 9
Cash & Equivalents 10 8 8
Other Assets 0 0 0
Total Assets 81 77 82
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 14 12 17
Creditors after 1 year 4 4 5
Other Liabilities 0 0 0
Total Liabilities 17 17 21
Net assets 64 61 61
Equity (£m) 2018 2017 2016
Called up share capital 5 5 5
Share Premium 0 0 95
Profit / Loss 12 4 -1
Other Equity 6 5 6
Preference & Minorities 0 1 1
Total Capital Employed 64 61 61
Ratios 2018 2017 2016
Debt Ratio 5.72 6.69 7.41
Debt-to-Equity 0.22 0.26 0.23
Net Gearing 8.84 10.96 16.48
Gross Gearing 21.48 21.59 26.04
Assets / Equity 1.27 1.28 1.35
Cash / Equity 16.09 13.56 12.91
EPS 2.21 0.59 -0.10
Cash Flow (£m) 2018 2017 2016
Cash from operating activities 8 9 9
Cashflow before financing 3 7 8
Increase in Cash 2 1 5
Income (£m) 2018 2017 2016
Turnover 43 42 39
Cost of sales 20 19 20
Gross Profit 23 23 18
Operating Profit 12 5 -0
Pre-Tax profit 12 4 -1
Profit / Loss for the year 5 5 5

EKF Diagnostics Holdings Company Background

Sector Medical Equipment
Activities EKF Diagnostics Holdings plc (formerly International Brand Licensing plc) is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.
Latest Interim Date 19 Sep 2018
Latest Fiscal Year End Date 13 Mar 2019

EKF Diagnostics Holdings Directors

Appointed Director Position
26 Nov 2009 Julian Huw Baines Chief Executive Officer
28 Sep 2011 Richard Anthony Evans Group Finance Director
08 Apr 2016 Christopher Harwood Bernard Mills Non-Executive Chairman
11 Oct 2004 Adam Reynolds Non-Executive Director
11 Jul 2016 Carl Dominic Contadini Non-Executive Director

EKF Diagnostics Holdings Contact Details

Company Name EKF Diagnostics
Company Address Avon House, 19 Stanwell Road, Penarth, Cardiff CF64 2EZ.
Company Telephone +44 (0)29 20 710570
Company Website http://www.ekfdiagnostics.com/

EKF Diagnostics Holdings Advisors

Auditor Name PricewaterhouseCoopers LLP
Auditor Address One Kingsway, Cardiff CF10 3PW.
Auditor Website http://www.pwc.co.uk/
Auditor Telephone +44 (0) 29 2023 7000
Registrar Name Capita Registrars
Registrar Address Northern House, Woodsome Park, Fenay Bridge, Huddersfield, West Yorkshire HD8 0LA.
Registrar Website http://www.capitaregistrars.com/
Registrar Telephone 0870 162 3100
Broker Name Canaccord Genuity Limited
Broker Address 88 Wood Street, London EC2V 7QR.
Broker Website http://www.canaccordgenuity.com/
Broker Telephone +44 (0)20 7523 8000
Adviser Name Canaccord Genuity Limited
Adviser Address 88 Wood Street, London EC2V 7QR.
Adviser Website http://www.canaccordgenuity.com/
Adviser Telephone +44 (0)20 7523 8000
Solicitor Name Memery Crystal LLP
Solicitor Address 44 Southampton Buildings, London WC2A 1AP.
Solicitor Website http://www.memerycrystal.com/
Solicitor Telephone +44 (0) 20 7242 5905
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a